Bank Of America Corp Biocryst Pharmaceuticals Inc Call Options Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	BUY	$7.94 - $11.84 $178,650 - $266,400	22,500 New	22,500 $187,000
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $92,480 - $158,080	8,000 Added 36.36%	30,000 $488,000
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $397,880 - $494,199	-28,000 Reduced 56.0%	22,000 $316,000
Q2 2021 Sep 13, 2021	BUY	$9.5 - $17.24 $475,000 - $861,999	50,000 New	50,000 $790,000

258

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.44B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.